Common Contracts
5 similar Securities Purchase Agreement contracts by Antigenics Inc /De/, Armen Garo H
ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of August 3, 2009, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors signatory hereto and identified for convenience on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 3rd, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of July 30, 2009, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors signatory hereto and identified for convenience on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of April 8, 2008, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors signatory hereto and identified for convenience on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 22nd, 2008 • Armen Garo H • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of January 9, 2008, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors identified on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
ANTIGENICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 11th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is made and entered into as of January 9, 2008, by and among Antigenics Inc., a Delaware corporation (the “Company”) and the investors identified on Schedule I attached hereto (each, a “Purchaser”, and collectively, the “Purchasers”).
